SEARCH

SEARCH BY CITATION

  • Blazev R. & Lamb, G. D. (1999). Adenosine inhibits depolarization-induced Ca2+ release in mammalian skeletal muscle. Muscle and Nerve 22, 16741683.
  • Fishbein W. N. (1999). Primary, secondary, and coincidental types of myoadenylate deaminase deficiency (letter). Annals of Neurology 45, 547548.
  • Fishbein W. N., Armbrustmacher, V. W. & Griffin, J. L. (1978). Myoadenylate deaminase deficiency: a new disease of muscle. Science 200, 545548.
  • Fishbein W. N., Foellmer, J. W. & Davis, J. I. (1990). Medical implications of the lactate and ammonia relationship in anaerobic exercise. International Journal of Sports Medicine 11 (suppl. 2), S91S100.
  • Flanagan W. F., Holmes, E. W., Sabina, R. L. & Swain, J. L. (1986). Importance of purine nucleotide cycle to energy production in skeletal muscle. American Journal of Physiology 251, C795802.
  • Gibala M. J., Maclean, D. A., Graham, T. E. & Saltin, B. (1997a). Anaplerotic processes in human skeletal muscle during brief dynamic exercise. Journal of Physiology 502, 703713.
  • Gibala M. J., Tarnopolsky, M. A. & Graham, T. E. (1997b). Tricarboxylic acid cycle intermediates in human muscle at rest and during prolonged cycling. American Journal of Physiology 272, E239244.
  • Graham T. E., Turcotte, L. P., Kiens, B. & Richter, E. A. (1995). Training and muscle ammonia and amino acid metabolism in humans during prolonged exercise. Journal of Applied Physiology 78, 725735.
  • Gross, M. (1997). Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. Journal of Inherited Metabolic Diseases 20, 186192.
  • Heinrikson R. L. & Meredith, S. C. (1984). Amino acid analysis by reverse phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Analytical Biochemistry 36, 6574.
  • Hisatome, I., Morisake, T., Kamma, H., Sugama, T., Morisaki, H., Ohtahara, A. & Holmes, E. W. (1998). Control of AMP deaminase 1 binding to myosin heavy chain. American Journal of Physiology 275, C870881.
  • Kelemen, J., Rice, D. R., Bradley, W. G., Munsat, T. L., Dimauro, S. & Hogan, E. L. (1982). Familial myoadenylate deaminase deficiency and exertional myalgia. Neurology 32, 857863.
  • Meyer R. A. & Terjung, R. L. (1980). AMP deamination and IMP reamination in working skeletal muscle. American Journal of Physiology 239, C3238.
  • Mineo I. & Tarui, S. (1995). Myogenic hyperuricemia: What can we learn from metabolic myopathies Muscle and Nerve (suppl. 3), S75S81.
  • Morisaki, T., Gross, M., Morisaki, H., Pongratz, D., Zollner, N. & Holmes, E. W. (1992). Molecular basis of AMP deaminase deficiency in skeletal muscle. Proceedings of the National Academy of Sciences of the USA 89, 64576461.
  • Norman, B., Glenmark, B. & Jansson, E. (1995). Muscle AMP deaminase deficiency in 2 % of a healthy population. Muscle and Nerve 18, 239241.
  • Norman, B., Mahnke-Zizelman, D. K., Vallis, A. & Sabina, R. L. (1998). Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. Journal of Applied Physiology 85, 12731278.
  • Passoneau J. A. & Lowry, O. H. (1993). Enzymatic Analysis: A Practical Guide, Humana Press, Totawa , NJ , USA .
  • Rush, J. W. E., Tullson, P. C. & Terjung, R. L. (1998). Molecular and kinetic alterations of muscle AMP deaminase during chronic creatine depletion. American Journal of Physiology 274, C465471.
  • Sabina R. L., Fishbein, W. N., Pezeshkpour, G., Clarke, P. R. H. & Holmes, E. W. (1992). Molecular analysis of the myoadenylate deaminase deficiencies. Neurology 42, 170179.
  • Sabina R. L., Swain, J. L., Patten, B. M., Ashizawa, T., O'brien, W. E. & Holmes, E. W. (1980). Disruption of the purine nucleotide cycle: A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency. Journal of Clinical Investigation 66, 14191423.
  • Sahlin K. & Broberg, S. (1990). Adenine nucleotide depletion in human muscle during exercise: Causality and significance of AMP deamination. International Journal of Sports Medicine 11 (suppl. 2), S62S67.
  • Sahlin, K., Jorfeldt, L., Henriksson, K. G., Lewis, S. F. & Haller, R. G. (1995). Tricarboxylic acid cycle intermediates during incremental exercise in healthy subjects and in patients with McArdle's disease. Clinical Science 88, 687693.
  • Sahlin, K., Katz, A. & Broberg, S. (1990). Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise. American Journal of Physiology 259, C834841.
  • Shumate J. B., Katnik, R., Ruiz, M., Kaiser, K., Frieden, C., Brooke, M. H. & Carroll, J. E. (1979). Myoadenylate deaminase deficiency. Muscle and Nerve 2, 21132116.
  • Sinkeler S. P., Binkhorst, R. A., Joosten, E. M., Wevers, R. A., Coerwinkei, M. M. & Oei, T. L. (1987). AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischemic isometric exercise. Clinical Science 72, 475482.
  • Tarnopolsky M. A., Atkinson, S. A., Phillips, S. M. & Macdougall, J. D. (1995). Carbohydrate loading and metabolism during exercise in males and females. Journal of Applied Physiology 78, 13601368.
  • Tarnopolsky M. A., Macguire, J., Myint, T., Applegarth, D. & Robinson, B. H. (1998). Clinical, physiological, and histological features in a kindred with the T3217C MELAS mutation. Muscle and Nerve 21, 2533.
  • Tarnopolsky M. A. & Parise, G. (1999). Direct measurement of high energy phosphate compounds in patients with neuromuscular disease. Muscle and Nerve 22, 12281233.
  • Tarnopolsky M. A., Rush, J. W. E., Stevens, L. & Macguire, J. (1999). The clinical utility of the forearm ischemic test lactate/ammonia response in the diagnosis of neuromuscular disorders: Insights into mitochondrial cytopathies and myoadenylate deaminase deficiency. Neurology 52, suppl. 2, A461.
  • Tullson P. C., Whitlock, D. M. & Terjung, R. L. (1990). Adenine nucleotide degradation in slow-twitch red muscle. American Journal of Physiology 258, C258265.
  • Verzijl H. T. F. M., van Engelen, B. G. M., Luyten, J. A. F. M., Steenbergen, G. C. H., van den Heuvel, L. P. W. J., Ter Laak, H. J., Padberg, G. W. & Wevers, R. A. (1998). Genetic characteristics of myoadenylate deaminase deficiency. Annals of Neurology 44, 140143.